Skip to content
AwardedMLTGoods€1,151,061

CT2339/2025 - Framework Contract for the supply of Risperidone Prolonged Release 25mg, 37.5mg and 50mg Injections

Published
Published 18 November 2025
Deadline
Closed 13 January 2026

Overview

A framework contract for the supply of Risperidone Prolonged Release injectable medications in three dosages (25mg, 37.5mg, and 50mg) has been awarded to A.M. Mangion Ltd for a value of 1,151,061 EUR. The contract was awarded on 22 April 2026 and is now complete.

Key details

Country
MLT
Status
Awarded
Category
Goods
Estimated value
€1,151,061
Procedure
Open
Published
18 November 2025
Deadline
Closed
Classification (CPV)
Various medicinal products

Award outcome

Awarded value
€1,151,061
Award date
22 April 2026
Winner
  • A.M. Mangion Ltd

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    27 April 2026

  2. Contract Notice

    18 November 2025

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: CT2339/2025 - Framework Contract for the supply of Risperidone Prolonged Release 25mg, 37.5mg and 50mg Injections — won by A.M. Mangion Ltd — Skim